Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides.
The acute and long-term effects of a single injection of psychomotor stimulants (amphetamine (1.5 mg/kg i.p.), cocaine (30 mg/kg i.p.) and GBR 12909 (10 mg/kg i.p.)) were studied with in situ hybridization histochemistry to assess alterations in the mRNA expression of enkephalin, dynorphin and substance P in the striatum. The greatest alterations on mRNA levels of enkephalin, dynorphin and substance P were observed 2 h following the first administration of each drug compared to that observed following a second challenge injection 14 days later. Of the drugs tested, the dopamine uptake inhibitory agents cocaine and GBR 12909 acutely elevated mRNA levels of all three neuropeptides, while amphetamine elevated mRNA levels of substance P only. A second challenge administration of the stimulants 14 days subsequent to the initial single injection re-elevated the mRNA level of substance P. An overall tolerance is speculated to account for diminution of the enkephalin and dynorphin responses to a challenge injection while a relative sensitization is suggested for the enkephalin response due to a reduction in the baseline level of expression produced by the first injection. The data also show that there are regional variation within the striatum following systemic administration of psychomotor stimulants, with greater elevations in the sensorimotor dorsolateral striatum than in the ventromedial 'limbic' nucleus accumbens region.
D000661:Amphetamine / Q000008:administration & dosage; D000818:Animals; D000697:Central Nervous System Stimulants / Q000008:administration & dosage*; D003042:Cocaine / Q000008:administration & dosage; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004399:Dynorphins / Q000235:genetics; D004745:Enkephalins / Q000235:genetics; D017403:In Situ Hybridization; D008297:Male; D009479:Neuropeptides / Q000235:genetics*; D014179:Neurotransmitter Uptake Inhibitors / Q000008:administration & dosage; D010879:Piperazines / Q000008:administration & dosage; D012333:RNA, Messenger / Q000096:biosynthesis / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013373:Substance P / Q000235:genetics
D000697:Central Nervous System Stimulants; D004745:Enkephalins; D009479:Neuropeptides; D014179:Neurotransmitter Uptake Inhibitors; D010879:Piperazines; D012333:RNA, Messenger; D013373:Substance P; D004399:Dynorphins; C043425:vanoxerine; D000661:Amphetamine; D003042:Cocaine